The week’s best buys

Amryt Pharma The Mail on Sunday

Amryt, which listed last year, acquires drugs that are in trials or just approved and develops them into medicines. Focused on rare diseases, with an experienced team and plenty of money. Buy. 17.75p.

Avon Rubber Investors Chronicle

Avon, which makes rubber products, such as masks, used in military kit and in the dairy industry, is enjoying a 45% uptick in its order book thanks to a “raft” of nearly commercialised products. The dividend has been hiked. Buy. £10.90.

British Land The Times

This real estate investment trust operates a “campus model”, with London properties in Paddington and Canada Water. Shares look cheap and the post-brexit vote collapse looks overdone. Yields 4.9%. Buy. 618.5p.

Firstgroup Investors Chronicle

The transport operator’s new South Western rail franchise has “significantly boosted” group revenues. Hurricanes hit US operations, but the worst is over. Shares trade at an “undeserved” discount to peers. Buy. 107.7p.

LVMH Investors Chronicle

The luxury conglomerate has revealed 12% sales growth, with strong cash-generation and profit margins. Its diverse portfolio has been bolstered by new products, including the first Louis Vuitton smartwatch. Buy. s245.

Vodafone The Times

The telecoms giant, with 444 million customers, has suffered a few “chequered” years. But first-half operating profits were s2bn, up from s1.5bn a year ago, and it is set to capitalise on growing consumer data usage. Buy. 228.86p.

Some conservatives still have not reconciled themselves to the reorientation, among them the Guinean cardinal Robert Sarah, who has been touted by introverts as a possible successor